Lv4
480 积分 2026-01-07 加入
Immune Checkpoint Inhibitors for Patients Aged ≥ 75 Years with Advanced Cancer in First- and Second-Line Settings: A Meta-Analysis
5个月前
已完结
Huaier suppresses cisplatin resistance in non-small cell lung cancer by inhibiting the JNK/JUN/IL-8 signaling pathway
5个月前
已完结
Efficacy and safety of immunotherapy in elderly patients with non-small cell lung cancer
5个月前
已完结
First-line atezolizumab monotherapy versus single-agent chemotherapy in patients with non-small-cell lung cancer ineligible for treatment with a platinum-containing regimen (IPSOS): a phase 3, global, multicentre, open-label, randomised controlled study
5个月前
已完结
Pulmonary blastoma is successfully treated with immunotherapy and targeted therapy
6个月前
已完结
Penpulimab and Anlotinib in PDL1 high-expression pulmonary giant cell carcinoma with cerebral metastases: case report and review
6个月前
已完结
Recurrent jejunal metastasis from occult lung cancer
6个月前
已完结
Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
6个月前
已完结
The lung immune prognostic index stratifies the occurrence of checkpoint inhibitor pneumonitis in advanced non-small cell lung cancer patients: a multi-institutional cohort study
6个月前
已完结
Pretreatment prognostic nutritional index as a novel biomarker in non-small cell lung cancer patients treated with immune checkpoint inhibitors
6个月前
已完结
皖公网安备34019202002308
